Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps.
Sorouri K, Lynce F, Feltmate CM, Davis MR, Muto MG, Konstantinopoulos PA, Stover EH, Kurian AW, Hill SJ, Partridge AH, Tolaney SM, Garber JE, Bychkovsky BL.
Sorouri K, et al. Among authors: davis mr.
JCO Precis Oncol. 2023 Sep;7:e2300290. doi: 10.1200/PO.23.00290.
JCO Precis Oncol. 2023.
PMID: 38061009
Free PMC article.
Review.